Terumo Corporation is a global leader in the medical device industry and is dedicated to developing innovative technologies for the treatment of cardiovascular disease. Every year the company invests significant resources into the research and development of new products. As a result, Terumo’s surgical portfolio for cardiac surgery is one of the most advanced in the industry.
The VirtuoSaph™ Plus EVH System allows saphenous vein and radial artery to be harvested using a minimally invasive technique. The system is designed to control branch length and reduce thermal spread providing excellent graft quality (Reference 1). The open CO2 system reduces the risk of CO2 embolism and intraluminal thrombosis therefore lowering risk to the patient (References 2,3,4)
AQUABRID® is a surgical sealant for aortic procedures. In contact with water AQUABRID® forms an elastic layer, while maintaining a strong seal in the aorta. It is safe and effective in achieving hemostasis, even under fully heparinized conditions (References .5,6,7,8,9).
Terumo’s Beating Heart and Surgical Stabilisation products provide a versatile combination of stabilisation, positioning and retraction during on- and off-pump cardiac surgery. Terumo recently introduced their Flex™ range which has been redesigned based on customer feedback. The Flex™ Beating Heart and Surgical Stabilisation product line offers even greater versatility, flexibility and a slimmer design (Reference 10).
Our mission is to work as a team to help save one more life, today and every day. We do this by providing lifesaving technology to cardiac surgery teams. Terumo is proud to sponsor the Society for Cardiothoracic Surgery Virtual Annual Meeting 2021. More information about our full range of products and services is available here.
Please contact Gemma Murphy, CV Marketing Assistant via email by clicking here.
1 Meyer DM, et al. Histologic evidence of the safety of endoscopic saphenous vein graft preparation. Annals of Thoracic Surgery: 2000 Aug, 70(2):487-91.
2 Brown et al. Strategies to reduce intraluminal clot formation in endoscopically harvested saphenous veins. J Thorac Cardiovasc Surg 2007; 134;1259-1265.
3 Burris et al. Incidence of residual clot strands in saphenous vein grafts after endoscopic harvest. Technology & Techniques in Cardiothorac & Vasc Surg 2006;1(6):323-327.
4 Burris et al. Catheter-based infrared light scanne ras a tool to assess conduit quality in coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007;133;419-42.
5 Eto et al. 2007: Elastomeric surgical sealant for hemostasis of cardiovascular anastomosis under full heparinization. Europ. J. Cardio Surg. 2007; 730-734.
6 Sales data Terumo Japan.
7 Morita et.al. 2019: Randomized clinical trial of an elastomeric sealant for hemostasis in thoracic aortic surgery; General Thoracic and Cardiovascular Surgery, p.1.
8 Umeda 2021: Distal stump construction for acute aortic dissection by pre-gluing felt strip with Hydrofit®; The Journal of Cardiovascular Surgery 2021
9 Naganuma 2021: New hemostatic technique with combined use of Hydrofit® and Surgicel®; The Japanese Society of Artificial Organs 2021
10 Internal testing, data on file.